Evidence map›Paper›PMID 41196894›Full record

ArticlePloS one2025

Broad-spectrum eye disease classification using a deep learning-based tailored software lens.

Celina Rieck, Luca Eisentraut, Ricardo Buettner

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Celina RieckChair of Hybrid Intelligence, Helmut-Schmidt-University/University of the Federal Armed Forces Hamburg, Hamburg, Germany.
Luca EisentrautChair of Hybrid Intelligence, Helmut-Schmidt-University/University of the Federal Armed Forces Hamburg, Hamburg, Germany.
Ricardo BuettnerChair of Hybrid Intelligence, Helmut-Schmidt-University/University of the Federal Armed Forces Hamburg, Hamburg, Germany.ORCID https://orcid.org/0000-0003-2263-6408

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The early and accurate classification of eye diseases is essential for preventing irreversible visual impairment. This task can be performed by deep learning approaches that automatically classify retinal fundus images according to potential illnesses. Despite notable advances in this field, the robust and methodologically rigorous classification of a broad range of eye diseases remains unsolved. This study addresses this issue by proposing a novel deep learning architecture that leverages specific features of retinal fundus images (e.g., image noise and importance of fine structures) using a tailored software lens to robustly diagnose a broad spectrum of illnesses at a high performance level. To validate this approach, the currently broadest peer-reviewed dataset of 16,242 images, comprising nine diseases and healthy samples, is chosen. Our novel architecture achieves a 5-fold cross-validated average balanced accuracy of 82.52 %, outperforming the baseline model (79.40 %) and setting a new benchmark. Our results demonstrate for the first time that high performance can be achieved for diagnosing a broad range of eye diseases based on retinal fundus images by leveraging their specific features. This approach has implications for clinical deployment, particularly in routine care settings, by enabling faster and more reliable screenings.

Indexed as

Deep LearningEye DiseasesSoftwareFundus OculiHumansImage Processing, Computer-AssistedRetina

Identifiers

PMID41196894
PMCPMC12591463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.